SCHEMBL14326318

SCHEMBL14326318

COC(=O)C(Cc1ccc(C(=O)OC(C)(C)C)cc1)NC(=O)C(C)NC(=O)C(C)NC(=O)C(C)NC(=O)CNC(=O)OCC1c2ccccc2-c2ccccc21

nearest known ligand 0.44

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ KLK5 Q9Y337 1/20 0.41
▸ REN P00797 2/20 0.39
▸ PTPN1 P18031 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14326320 0.92 KLK5 (0.42) KLK5PTPN1
SCHEMBL14326319 0.92 KLK5 (0.42) KLK5PTPN1
SCHEMBL14326321 0.91 KLK5 (0.43) KLK5PTPN1
SCHEMBL15674296 0.86 KLK5 (0.45) KLK5PTPN1
SCHEMBL13318926 0.86 KLK5 (0.45) KLK5PTPN1
SCHEMBL30278724 0.86 KLK5 (0.45) KLK5PTPN1
SCHEMBL27433838 0.80 PDK2 (0.44) KLK5PTPN1
SCHEMBL29397165 0.80 ATM (0.50) —
SCHEMBL17020392 0.80 ATM (0.50) —
SCHEMBL23080684 0.80 MDM2 (0.43) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8338565-B2 Macrocyclic compounds for inhibition of tumor necrosis factor alpha ENSEMBLE THERAPEUTICS CORPORATION (US) 2012-12-25 — — US disclosed
Send feedback